- |||||||||| Neupogen (filgrastim) / Kyowa Kirin, Amgen, Oncaspar liquid (pegaspargase) / Servier, lestaurtinib (CEP-701) / Teva, Kyowa Kirin
Clinical: Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Aug 21, 2014 P3, N=242, Active, not recruiting, Completed --> Active, not recruiting N=315 --> 242
- |||||||||| TheraSphere (yttrium 90 microspheres) / Boston Scientific
Enrollment closed, Trial primary completion date: Phase II Trial Evaluating OS With Therasphere (clinicaltrials.gov) - Aug 21, 2014 P2, N=58, Active, not recruiting, Active, not recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2016 --> Mar 2015
- |||||||||| telisotuzumab (h224G11) / AbbVie
Trial primary completion date, Metastases: Study of ABT-700 in Subjects With Advanced Solid Tumors (clinicaltrials.gov) - Aug 19, 2014 P1, N=124, Recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2016 --> Mar 2015 Trial primary completion date: Dec 2014 --> Dec 2015
- |||||||||| Trial primary completion date, Metastases: Molecularly Tailored Therapy for Pancreas Cancer (clinicaltrials.gov) - Aug 15, 2014
P2, N=20, Recruiting, Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Dec 2014 --> Jun 2015
- |||||||||| 5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg., irinotecan / Generic mfg.
Trial primary completion date, Metastases: Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC (clinicaltrials.gov) - Aug 15, 2014 P3, N=390, Active, not recruiting, Trial primary completion date: Dec 2014 --> Jun 2015 Trial primary completion date: Jan 2014 --> Sep 2014
- |||||||||| Rituxan (rituximab) / Roche
Trial primary completion date, Combination therapy: R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma (clinicaltrials.gov) - Aug 8, 2014 P2, N=22, Active, not recruiting, Initiation date: Jan 2013 --> Sep 2013 Trial primary completion date: Apr 2014 --> Apr 2015
- |||||||||| Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial primary completion date, IO biomarker, Surgery: acns0333: Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System (clinicaltrials.gov) - Aug 6, 2014 P3, N=70, Active, not recruiting, Trial primary completion date: Oct 2012 --> Jun 2014 Trial primary completion date: Apr 2014 --> Apr 2015
- |||||||||| Avastin (bevacizumab) / Roche
Trial primary completion date, Combination therapy, Metastases: Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer (clinicaltrials.gov) - Aug 1, 2014 P1, N=18, Active, not recruiting, Trial primary completion date: Oct 2015 --> Oct 2016 Trial primary completion date: May 2013 --> Aug 2014
- |||||||||| Erbitux (cetuximab) / Eli Lilly
Enrollment open, Trial initiation date, Trial primary completion date, Surgery, Metastases: ECKINOXE: Trial of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer (clinicaltrials.gov) - Jul 30, 2014 P2, N=186, Recruiting, Trial primary completion date: Jun 2014 --> Dec 2014 Not yet recruiting --> Recruiting | Initiation date: Jan 2014 --> May 2012 | Trial primary completion date: Feb 2014 --> May 2012
- |||||||||| Enrollment open, Trial initiation date, Trial primary completion date, Combination therapy, Metastases: Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer (clinicaltrials.gov) - Jul 24, 2014
P2, N=30, Recruiting, N=180 --> 53 | Recruiting --> Terminated | Trial primary completion date: Dec 2016 --> Jun 2015 Not yet recruiting --> Recruiting | Initiation date: Aug 2013 --> Jul 2014 | Trial primary completion date: Jul 2015 --> Jul 2016
- |||||||||| sapitinib (AZD8931) / AstraZeneca
Enrollment open, Trial initiation date, Combination therapy: PANTHER: Phase I/II Trial of Antagonism of HER in GI Cancer (clinicaltrials.gov) - Jul 23, 2014 P1/2, N=24, Recruiting, Active, not recruiting --> Completed | N=90 --> 221 Not yet recruiting --> Recruiting | Initiation date: Aug 2013 --> May 2014
|